{"transactions":[{"id":853228,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-09T16:35:20.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":744960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 5, 2026."}],"balance_after":744960,"derivative":{"exercise_price":1.53,"expiration_date":"2036-03-05","underlying":"Common Stock","underlying_shares":744960},"source":{"system":"sec-edgar","filing":"0001341642-26-000002","document":"form4-03092026_080314.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164226000002/form4-03092026_080314.xml","form_type":"4"}},{"id":1011812,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-29T16:11:57.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":false,"shares":220643,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":220643},"source":{"system":"sec-edgar","filing":"0001341642-25-000004","document":"form4-10292025_081048.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164225000004/form4-10292025_081048.xml","form_type":"4"}},{"id":1011811,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-10-29T16:11:57.000Z","date":"2025-10-27","kind":"exercise","planned":false,"acquired":true,"shares":220643,"price":1.37,"value":302280.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes 305,667 shares previously reported as held directly by the reporting person which were re-registered on August 13, 2025 and are now held of record by the Mack-Mulligan Revocable Trust  (the \"Revocable Trust\")."}],"balance_after":451109,"source":{"system":"sec-edgar","filing":"0001341642-25-000004","document":"form4-10292025_081048.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000134164225000004/form4-10292025_081048.xml","form_type":"4"}},{"id":1092020,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-03T19:48:00.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":58411,"price":1.0645,"value":62178.5095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025."}],"balance_after":536133,"source":{"system":"sec-edgar","filing":"0001415889-25-019380","document":"form4-07032025_110757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925019380/form4-07032025_110757.xml","form_type":"4"}},{"id":1221895,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T18:30:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025."}],"balance_after":800000,"derivative":{"exercise_price":1.32,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001415889-25-007071","document":"form4-03052025_110346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925007071/form4-03052025_110346.xml","form_type":"4"}},{"id":1297333,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-22T16:37:33.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":17709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":17709},"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297332,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-22T16:37:33.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":false,"shares":91750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":17709,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":91750},"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297331,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T16:37:33.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":17709,"price":0.53,"value":9385.77,"ownership":{"direct":true},"balance_after":551919,"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1297330,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-22T16:37:33.000Z","date":"2024-12-03","kind":"exercise","planned":false,"acquired":true,"shares":91750,"price":0.53,"value":48627.5,"ownership":{"direct":true},"balance_after":534210,"source":{"system":"sec-edgar","filing":"0001415889-25-001853","document":"form4-01222025_090129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588925001853/form4-01222025_090129.xml","form_type":"4"}},{"id":1391636,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":330000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter."}],"balance_after":330000,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391635,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":330000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 330,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 330,000 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391634,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":384184,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter."}],"balance_after":384184,"derivative":{"exercise_price":1.48,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":384184},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391633,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":249600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 249,600 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 249,600 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":0,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":249600},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1391632,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-10-03T16:44:08.000Z","date":"2024-08-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":134584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 134,584 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 134,584 shares, having an exercise price of $1.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":0,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":134584},"source":{"system":"sec-edgar","filing":"0001415889-24-024622","document":"form4-10032024_081002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000141588924024622/form4-10032024_081002.xml","form_type":"4"}},{"id":1674051,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-22T16:02:42.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":519915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024."}],"balance_after":519915,"derivative":{"exercise_price":1.8,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":519915},"source":{"system":"sec-edgar","filing":"0001209191-24-001993","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919124001993/doc4.xml","form_type":"4"}},{"id":1674050,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-22T16:02:42.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":163890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025."}],"balance_after":442460,"source":{"system":"sec-edgar","filing":"0001209191-24-001993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919124001993/doc4.xml","form_type":"4"}},{"id":1743501,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-11-13T16:21:30.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"shares":198407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":109459,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":198407},"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743500,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-11-10","kind":"gift","planned":false,"acquired":true,"shares":85307,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":165307,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743499,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-11-10","kind":"gift","planned":false,"acquired":false,"shares":85307,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":278570,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1743498,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-11-13T16:21:30.000Z","date":"2023-10-18","kind":"exercise","planned":false,"acquired":true,"shares":198407,"price":0.53,"value":105155.71,"ownership":{"direct":true},"balance_after":363877,"source":{"system":"sec-edgar","filing":"0001209191-23-054997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123054997/doc4.xml","form_type":"4"}},{"id":1812775,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-08T16:43:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":false,"shares":85500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":307866,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":85500},"source":{"system":"sec-edgar","filing":"0001209191-23-045010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123045010/doc4.xml","form_type":"4"}},{"id":1812774,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-08T16:43:13.000Z","date":"2023-08-07","kind":"exercise","planned":false,"acquired":true,"shares":85500,"price":0.53,"value":45315.0,"ownership":{"direct":true},"balance_after":165470,"source":{"system":"sec-edgar","filing":"0001209191-23-045010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123045010/doc4.xml","form_type":"4"}},{"id":1893185,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-05-15T17:48:03.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2023."}],"balance_after":330000,"derivative":{"exercise_price":5.7,"expiration_date":"2033-05-12","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001209191-23-029586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919123029586/doc4.xml","form_type":"4"}},{"id":2287707,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-29T21:15:13.000Z","date":"2022-04-27","kind":"exercise","acquired":false,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Due to an administrative error, the Form 4 filed on May 24, 2021 overstated the number of derivative securities beneficially owned following the reported transaction by 6,207 shares and has been updated in this Form 4 to correct the error."}],"balance_after":393366,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-22-026341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122026341/doc4.xml","form_type":"4"}},{"id":2287706,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-04-29T21:15:13.000Z","date":"2022-04-27","kind":"exercise","acquired":true,"shares":33000,"price":0.53,"value":17490.0,"ownership":{"direct":true},"balance_after":79970,"source":{"system":"sec-edgar","filing":"0001209191-22-026341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122026341/doc4.xml","form_type":"4"}},{"id":2341352,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T16:33:25.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":220644,"derivative":{"exercise_price":1.37,"expiration_date":"2026-11-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-017591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122017591/doc4.xml","form_type":"4"}},{"id":2341351,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-09T16:33:25.000Z","date":"2021-03-09","kind":"gift","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001209191-22-017591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122017591/doc4.xml","form_type":"4"}},{"id":2341350,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-09T16:33:25.000Z","date":"2021-03-09","kind":"gift","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":147915,"source":{"system":"sec-edgar","filing":"0001209191-22-017591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122017591/doc4.xml","form_type":"4"}},{"id":2341349,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-09T16:33:25.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":20000,"price":1.37,"value":27400.0,"ownership":{"direct":true},"balance_after":46970,"source":{"system":"sec-edgar","filing":"0001209191-22-017591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122017591/doc4.xml","form_type":"4"}},{"id":2368511,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-28T16:12:59.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":249600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022."}],"balance_after":249600,"derivative":{"exercise_price":16.29,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":249600},"source":{"system":"sec-edgar","filing":"0001209191-22-013544","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919122013544/doc4.xml","form_type":"4"}},{"id":2469578,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-16T21:57:36.000Z","date":"2021-12-15","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":432574,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-070116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121070116/doc4.xml","form_type":"4"}},{"id":2469577,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-16T21:57:36.000Z","date":"2021-12-15","kind":"exercise","acquired":true,"shares":9000,"price":0.53,"value":4770.0,"ownership":{"direct":true},"balance_after":26970,"source":{"system":"sec-edgar","filing":"0001209191-21-070116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121070116/doc4.xml","form_type":"4"}},{"id":2469576,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-16T21:57:36.000Z","date":"2021-12-09","kind":"gift","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001209191-21-070116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121070116/doc4.xml","form_type":"4"}},{"id":2469575,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-16T21:57:36.000Z","date":"2021-12-09","kind":"gift","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein."}],"balance_after":187915,"source":{"system":"sec-edgar","filing":"0001209191-21-070116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121070116/doc4.xml","form_type":"4"}},{"id":2594590,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-20T16:41:45.000Z","date":"2021-08-19","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":441574,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001209191-21-052787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121052787/doc4.xml","form_type":"4"}},{"id":2594589,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-08-20T16:41:45.000Z","date":"2021-08-19","kind":"exercise","acquired":true,"shares":5500,"price":0.53,"value":2915.0,"ownership":{"direct":true},"balance_after":17970,"source":{"system":"sec-edgar","filing":"0001209191-21-052787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121052787/doc4.xml","form_type":"4"}},{"id":2627019,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":26767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":447074,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":26767},"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2627018,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-20","kind":"exercise","acquired":false,"shares":1029,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":473841,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":1029},"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2627017,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":26767,"price":35.7564,"value":957091.5588,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $36.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":12470,"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2627016,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":26767,"price":0.53,"value":14186.51,"ownership":{"direct":true},"balance_after":39237,"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2627015,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-20","kind":"sale","acquired":false,"shares":1029,"price":35.53,"value":36560.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":12470,"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2627014,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-22T16:24:13.000Z","date":"2021-07-20","kind":"exercise","acquired":true,"shares":1029,"price":0.53,"value":545.37,"ownership":{"direct":true},"balance_after":13499,"source":{"system":"sec-edgar","filing":"0001209191-21-047745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121047745/doc4.xml","form_type":"4"}},{"id":2651398,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-29T18:09:04.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":474870,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":204},"source":{"system":"sec-edgar","filing":"0001209191-21-043738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121043738/doc4.xml","form_type":"4"}},{"id":2651397,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-29T18:09:04.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":204,"price":35.53,"value":7248.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."}],"balance_after":12470,"source":{"system":"sec-edgar","filing":"0001209191-21-043738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121043738/doc4.xml","form_type":"4"}},{"id":2651396,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-29T18:09:04.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":204,"price":0.53,"value":108.12,"ownership":{"direct":true},"balance_after":12674,"source":{"system":"sec-edgar","filing":"0001209191-21-043738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121043738/doc4.xml","form_type":"4"}},{"id":2677160,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-06-08T19:08:40.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":134584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021."}],"balance_after":134584,"derivative":{"exercise_price":28.33,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":134584},"source":{"system":"sec-edgar","filing":"0001209191-21-039028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121039028/doc4.xml","form_type":"4"}},{"id":2680575,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T19:13:27.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":475074,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-038419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121038419/doc4.xml","form_type":"4"}},{"id":2680574,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-06-04T19:13:27.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":10000,"price":0.53,"value":5300.0,"ownership":{"direct":true},"balance_after":12470,"source":{"system":"sec-edgar","filing":"0001209191-21-038419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121038419/doc4.xml","form_type":"4"}},{"id":2698420,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":6207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":485074,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":6207},"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2698419,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-20","kind":"exercise","acquired":false,"shares":7793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":492867,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":7793},"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2698418,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":6207,"price":35.7083,"value":221641.4181,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive."}],"balance_after":2470,"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2698417,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":6207,"price":0.53,"value":3289.71,"ownership":{"direct":true},"balance_after":8677,"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2698416,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-20","kind":"sale","acquired":false,"shares":7793,"price":35.6031,"value":277454.9583,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":2470,"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2698415,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-24T16:52:50.000Z","date":"2021-05-20","kind":"exercise","acquired":true,"shares":7793,"price":0.53,"value":4130.29,"ownership":{"direct":true},"balance_after":10263,"source":{"system":"sec-edgar","filing":"0001209191-21-035364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919121035364/doc4.xml","form_type":"4"}},{"id":2970980,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T16:12:32.000Z","date":"2020-11-18","kind":"exercise","acquired":false,"shares":2470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are subject to the terms of a lock-up agreement, dated June 23, 2020 (the \"Lock-Up Agreement\"). This report on Form 4 is  in accordance with Section (v) of the Lock-Up Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":492867,"derivative":{"exercise_price":0.53,"expiration_date":"2025-05-11","underlying":"Common Stock","underlying_shares":2470},"source":{"system":"sec-edgar","filing":"0001209191-20-059634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919120059634/doc4.xml","form_type":"4"}},{"id":2970979,"issuer":{"id":7062,"kind":"organization","name":"PMV Pharmaceuticals, Inc.","symbol":"PMVP"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-11-20T16:12:32.000Z","date":"2020-11-18","kind":"exercise","acquired":true,"shares":2470,"price":0.53,"value":1309.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are subject to the terms of a lock-up agreement, dated June 23, 2020 (the \"Lock-Up Agreement\"). This report on Form 4 is  in accordance with Section (v) of the Lock-Up Agreement."}],"balance_after":2470,"source":{"system":"sec-edgar","filing":"0001209191-20-059634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341642/000120919120059634/doc4.xml","form_type":"4"}},{"id":3132039,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-28T20:01:05.000Z","date":"2020-05-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of May 5, 2020, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":3,"expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-20-011290","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761920011290/doc1.xml","form_type":"4"}},{"id":3525950,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-15T19:02:53.000Z","date":"2019-05-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option will vest quarterly over one year from the grant date of May 14, 2019, such that the shares will be fully vested on the first anniversary of the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":3.29,"expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-19-011352","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761919011352/doc1.xml","form_type":"4"}},{"id":3641702,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":61989,"kind":"person","name":"Mack David Henry","position":1,"cik":"0001341642","reported_name":"Mack David Henry","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Initial Option Grant","published_at":"2019-02-21T16:38:30.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the initial option grant vest 1/3 after the first year, the remaining shares will vest quarterly in years two and three following the grant date of February 19, 2019."}],"balance_after":40000,"derivative":{"exercise_price":3.88,"expiration_date":"2029-02-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-19-005097","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000156761919005097/doc1.xml","form_type":"4"}}]}